Abortive segmental perineal hemangioma.
A six-week-old girl presented with a segmental, focally atrophic, vascular patch in the diaper area, present since birth. It had undergone minimal proliferation, but had ulcerated. Evaluation to rule out LUMBAR (Lower body hemangioma/Lipoma or other cutaneous anomalies, Urogenital anomalies, Myelopathy, Bony deformities, Anorectal/Arterial anomalies, and Renal anomalies) syndrome, which included ultrasound and Doppler examination of the abdomen, spine, and pelvis, was negative. We report a unique case of an ulcerated, segmental abortive hemangioma of the anogenital area with excellent clinical response to topical timolol gel.
Department of Dermatology, New York University, New York, New York, USA.
Brook E
BE
Tlougan
Mercedes E
ME
Gonzalez
Seth J
SJ
Orlow
D000279:Administration, Cutaneous; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D005260:Female; D051272:Glucose Transporter Type 1 / Q000032:analysis; D006391:Hemangioma / Q000737:chemistry / Q000150:complications / Q000151:congenital* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007223:Infant; D010502:Perineum / Q000473:pathology*; D012878:Skin Neoplasms / Q000737:chemistry / Q000150:complications / Q000151:congenital* / Q000188:drug therapy / Q000473:pathology; D012883:Skin Ulcer / Q000209:etiology; D013999:Timolol / Q000008:administration & dosage / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D014408:Biomarkers, Tumor; D051272:Glucose Transporter Type 1; D013999:Timolol